DexCom (DXCM) PT Raised to $95 at TD Cowen as 'CONNECT and MACE Data Impress at ADA' Jun 10, 2026 08:30AM
DexCom (DXCM) PT Raised to $85 at Mizuho Jun 9, 2026 06:42AM
Dexcom study shows glucose monitor reduces A1C in type 2 diabetes patients Jun 6, 2026 03:18PM
Dexcom to present diabetes study results and launch updated glucose app Jun 4, 2026 09:05AM
Dexcom reports theft of scrapped glucose sensors sold to customers May 26, 2026 09:30AM
View Older Stories

May 18, 2026 07:17AM DexCom (DXCM) PT Lowered to $82 at Canaccord
May 18, 2026 05:44AM DexCom (DXCM) PT Lowered to $80 at BofA Securities
May 15, 2026 08:55AM Piper Sandler on DexCom (DXCM): 'Well Done Investor Meeting Provides Excellent Stock Setup'
May 15, 2026 08:31AM Truist on DexCom (DXCM): 'Catalyst Rich 27-28 Ahead'
May 15, 2026 07:54AM DexCom (DXCM) Reiterated at Buy by Benchmark After Investor Event
May 14, 2026 04:31PM After-hours movers: AMAT, FIG, DXCM, DLO, STNE, PZZA
May 14, 2026 04:03PM Dexcom adds two directors, expands board committee following Elliott talks
May 12, 2026 08:51AM TD Cowen Reiterates Buy Rating on DexCom (DXCM)
May 12, 2026 05:48AM Benchmark Starts DexCom (DXCM) at Buy
May 1, 2026 06:49AM DexCom (DXCM) PT Raised to $100 at Canaccord
May 1, 2026 05:32AM DexCom (DXCM) PT Lowered to $77 at Bernstein SocGen Group
May 1, 2026 05:12AM DexCom (DXCM) PT Lowered to $75 at Mizuho
Apr 30, 2026 04:03PM DexCom (DXCM) Tops Q1 EPS by 9c; offers guidance
Apr 2, 2026 08:48AM TD Cowen Highlights a 'Compelling 2026-2028 Margin Story' at DexCom (DXCM)
Mar 24, 2026 06:13AM Evercore ISI Upgrades DexCom (DXCM) to Outperform, 'Turning the page to T2 NIT expansion'
Mar 9, 2026 08:18AM Piper Sandler: 'When Will Things Turn in Med Tech and What Names to Own Now?'
Feb 13, 2026 08:42AM DexCom (DXCM) PT Lowered to $95 at Canaccord Genuity
Feb 13, 2026 02:43AM Stifel Reiterates Buy Rating on DexCom (DXCM)
Feb 12, 2026 04:05PM DexCom (DXCM) Tops Q4 EPS by 3c ; Offers Guidance
Feb 5, 2026 08:36AM Piper Sandler on DexCom (DXCM): 'Encouraged About the Stock Setup Over the Long-Term'
Jan 12, 2026 10:45AM Jefferies on DexCom (DXCM): 'We think the '26 guide is conservative, leaving room for upside in stock'
Jan 12, 2026 09:34AM Barclays Downgrades Insulet Corporation (PODD) to Underweight
Jan 12, 2026 09:34AM Barclays Downgrades DexCom (DXCM) to Underweight
Jan 12, 2026 09:04AM Morgan Stanley Reiterates Overweight Rating on DexCom (DXCM), 'Prelim Results Likely Clear the Bar'
Jan 12, 2026 09:01AM Citi Opens 90-Day Upside Catalyst Watch on DexCom (DXCM)
Jan 12, 2026 07:31AM Dexcom reports Q4 revenue of $1.26 billion, provides 2026 outlook
Jan 9, 2026 07:33AM Bernstein Highlights Top U.S. Medtech 2026 Picks: 'Sector Poised For a Rebound'
Jan 7, 2026 10:43AM Goldman: 'Top Call Buying Opportunities for 2026'
Jan 5, 2026 11:00PM BofA’s six MedTech picks for 2026 on strong earnings growth
Dec 18, 2025 11:51AM Raymond James Reiterates Strong Buy Rating on Jabil (JBL)
Dec 16, 2025 06:19AM DexCom (DXCM) PT Raised to $92 at Leerink Partners
Dec 15, 2025 07:42AM Bernstein Shares Takeaways From the 5th Annual Diabetes Disruptor Conference
Dec 11, 2025 05:09AM DexCom (DXCM) Added to Citi 90-Day Upside Catalyst Watch List
Nov 25, 2025 06:03AM Evercore ISI Starts DexCom (DXCM) at In Line
Nov 20, 2025 08:31AM Dexcom launches 15-day glucose monitor in US on Dec. 1
Nov 19, 2025 08:30AM Dexcom receives FDA clearance for basal insulin dosing optimizer
Nov 3, 2025 07:03AM 'DexCom (DXCM) Too Cheap to Ignore'; Stock PT Lowered at Bernstein
Oct 31, 2025 01:30PM This medtech stock is "objectively too cheap," BofA says
Oct 31, 2025 09:11AM DexCom (DXCM) PT Lowered at Piper Sandler; 'We Strongly Recommend Investors Buy the Stock'
Oct 31, 2025 03:36AM DexCom (DXCM) PT Lowered to $85 at BTIG
Oct 31, 2025 03:31AM DexCom (DXCM) PT Lowered to $99 at Canaccord Genuity
Oct 30, 2025 04:05PM DexCom (DXCM) Tops Q3 EPS by 4c ; Offers Guidance
Oct 30, 2025 02:35PM DexCom (DXCM) call put ratio 3.2 calls to 1 put with a focus on October 31 weekly 75 and 80 calls
Oct 28, 2025 11:03AM DexCom (DXCM) Mentioned Cautiously Again at Hunterbrook
Oct 24, 2025 09:07AM TD Cowen on DexCom (DXCM): 'G7 Angst Has Created Attractive Risk/Reward Setup Into Q3 Print'
Oct 21, 2025 08:52AM Piper Sandler Sees Good Setup for DexCom (DXCM) Stock, Recommends Purchase
Oct 20, 2025 04:31PM Stifel Resumes DexCom (DXCM) at Buy
Sep 25, 2025 09:23AM TD Cowen on DexCom (DXCM): ' G7 Issues Are Mostly Resolved, Limiting Share Shifts'
Sep 22, 2025 09:23AM UBS Reiterates Buy Rating on DexCom (DXCM) Following Over 10% Selloff
Sep 18, 2025 09:05AM DexCom (DXCM) Mentioned as short at Hunterbrook
View Older Stories